Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
Machin, D.; Andersen, K.W.
Journal of the National Cancer Institute 89(9): 659-660
1997
ISSN/ISBN: 0027-8874 PMID: 9150193 Document Number: 482053
Document emailed within 1 workday
Related Documents
1988: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women New England Journal of Medicine 319(26): 1681-1692Gori, S.; Anastasi, P.; Marrocolo, F. 2004: Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S27-S31
Bardi, M.; Arnoldi, E.; Pizzocchero, G.; Pezzica, E.; Mattioni, D.; Perotti, M. 1994: Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report European Journal of Gynaecological Oncology 15(5): 393-395
Marshall, J.S.; Gordon, N.H.; Hubay, C.A.; Pearson, O.H. 1987: Assessment of tamoxifen as adjuvant therapy in stage Ii breast cancer: a long-term follow-up Journal of Laboratory and Clinical Medicine 109(3): 300-307
Gershanovich, M.L.; Garin, A.M.; Baltinia, D.; Kurvet, A.; Kangas, L.; Ellmen, I. 1997: Results of phase Ii clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women Voprosy Onkologii 43(6): 587-595
Lipton, A.; Harvey, H.A.; Santen, R.J.; Boucher, A.; White, D.; Bernath, A.; Dixon, R.; Richards, G.; Shafik, A. 1982: Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer Cancer Research 42(8 Suppl): 3434s-3436s
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Gockerman, J.P.; Spremulli, E.N.; Raney, M.; Logan, T. 1986: Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial Cancer Treatment Reports 70(10): 1199-1203
Nesković-Konstantinović, Z.; Filipović, S. 2003: The role of endocrine therapy in early breast cancer: adjuvant treatment of preand postmenopausal patients Journal of Buon: Official Journal of the Balkan Union of Oncology 8(1): 11-17
Chiesa, M.Dalla.; Passalacqua, R.; Michiara, M.; Franciosi, V.; Di Costanzo, F.; Bisagni, G.; Camisa, R.; Buti, S.; Tomasello, G.; Cocconi, G. 2007: Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial Acta Bio-Medica: Atenei Parmensis 78(3): 204-209
Perez, E.; Muss, H.B. 2005: Optimizing adjuvant chemotherapy in early-stage breast cancer Oncology 19(14): 1759-1767; Discussion 1768: 1772-1774; 1777-1778
Lindahl, B.; Andolf, E.; Ingvar, C.; Ranstam, J.; Willén, R. 2008: Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma Anticancer Research 28(2b): 1259-1262
Wolff, A.C. 2005: Current status of taxanes as adjuvant therapy for early-stage breast cancer International Journal of Fertility and Women's Medicine 50(5 Pt 1): 227-229
Love, R.R.; Fost, N.C. 1997: Ethical and regulatory challenges in a randomized control trial of adjuvant treatment for breast cancer in Vietnam Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 45(8): 423-431
Powles, T.J.; Gordon, C.; Coombes, R.C. 1982: Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone Cancer Research 42(8 Suppl): 3458s-3460s
Sinawat, S.; Chiyabutra, T.; Kleabkaew, P. 2001: Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report Journal of the Medical Association of Thailand 84(7): 1033-1036
Spigel, D.R.; Hainsworth, J.D.; Burris, H.A.; Molthrop, D.C.; Peacock, N.; Kommor, M.; Vazquez, E.R.; Greco, F.A.; Yardley, D.A. 2011: A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer Clinical Advances in Hematology and Oncology: H&o 9(4): 280-286
2015: (S029) evaluating the role of a 21-gene expression assay in directing adjuvant radiotherapy decisions for elderly women with early-stage breast cancer Oncology 29(4 Suppl. 1)
Sonoo, H.; Senoo, T.; Nishiki, M.; Morimoto, T.; Takashima, S. 1996: Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(4): 447-454
2015: (S045) Equivalent Survival With Breast-Conserving Therapy and Mastectomy in Young Women Under the Age of 40 With Early-Stage Breast Cancer: A National Registry-Based Stage-by-Stage Comparison Oncology 29(4 Suppl. 1)